IRCT20151103024853N5已完成未知
Evaluation of Riluzol effect as adjunctive therapy in patients with standard treatment-resistant obsessive-compulsive disorder
Deputy of research and technology developement0 个研究点目标入组 32 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 65 years（—）
- 性别
- All
入选标准
- •Patients with known obsessive compulsive disorder by DSM-V criteria.
- •Not to use alcohol chronic.
- •The patient had no serious risk factor for respiratory apnea and pulmonary fibrosis and not be affected.
- •Between 18 to 65 years old
- •The individual should be treated with a maximum dose of SSRI for at least 6 months and scored 20 or higher on the Y-BOCS criterion.
- •The patient's liver transaminase should not be more than 5 times higher than normal.
排除标准
- •Pregnancy and nursing; Patients with a history of memantine use.
- •Patients who do not sign the ethical consent form or refuse to continue to participate in the study.
研究者
相似试验
进行中（未招募）
1 期
_Colorectal cancer stage II/III with adjuvant oxaliplatin-based chemotherapy (simplified FOLFOX4)EUCTR2017-002320-25-FRICANCER210
已完成
不适用
Evaluation of efficacy of Riluzole in the treatment of MethamphetaminePsychoactive substance use.Mental and behavioural disorders due to psychoactive substance useF10, F11,IRCT2016012826168N1Vice chancellor for research, Tehran University of Medical Sciences40
已完成
2 期
Troriluzole (BHV-4157) in Adult Participants With Obsessive Compulsive DisorderObsessive-Compulsive DisorderNCT03299166Biohaven Pharmaceuticals, Inc.426
尚未招募
2 期
The effect of Rosiglitazone in the treatment of depressioIRCT20090117001556N152Tehran University of Medical Sciences50
尚未招募
2 期
The effect of Rosiglitazone on negative symptoms in schizophreniaSchizophreniaIRCT20090117001556N159niversity of social welfare and rehabilitation sciences50